Francesca Happé’s research in cognitive neuroscience focuses specifically on autism and investigation of related typical and atypical developmental processes, particularly as they relate to social cognition.
Francesca Happé
Professor, King's College London
From this contributor
How autistic people use compensatory strategies to cope with daily life
In a large survey, autistic adults from around the world described their experiences of using psychological strategies to fit in.
How autistic people use compensatory strategies to cope with daily life
By
Francesca Happé, Lucy Anne Livingston, The Conversation
26 July 2019 | 4 min read
Male slant to research may skew autism’s reported sex ratio
Clinicians may need to go beyond the 'masks' to find autism in women.
Male slant to research may skew autism’s reported sex ratio
By
Francesca Happé
19 October 2015 | 6 min read
Remembering Lorna Wing (1928-2014)
Lorna Wing, who died in June, was the modest, kind and thoughtful mother of a daughter with severe autism. She was also a towering figure in the history of autism research, and her contributions to our understanding of autism cannot be overestimated.
Remembering Lorna Wing (1928-2014)
By
Francesca Happé, Simon Baron-Cohen
15 July 2014 | 7 min read
Why fold Asperger syndrome into autism spectrum disorder in the DSM-5?
In the new diagnostic manual for psychiatric disorders, Asperger syndrome will be folded into autism spectrum disorder. Francesca Happé, a member of the committee that made the recommendation, explains the rationale behind the decision.
Why fold Asperger syndrome into autism spectrum disorder in the DSM-5?
By
Francesca Happé
29 March 2011 | 8 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read